Standardized SEC financial data for ICU MEDICAL INC/DE — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0000883984 · NASDAQ · Surgical & Medical Instruments & Apparatus.
Ratios for fiscal year 2025, standardized from SEC filings.
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $1.27B | $1.32B | $2.28B | $2.26B | $2.38B | $2.23B |
| Cost of revenue | $809.5M | $824.8M | $1.58B | $1.52B | $1.56B | $1.41B |
| Gross profit | $461.5M | $491.5M | $697.8M | $739.9M |
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $410.8M | $567.2M | $213.0M | $254.7M | $308.6M | $308.0M |
| Inventory | $314.9M | $290.2M | $696.0M | $709.4M | $584.7M | $615.9M |
| Total current assets | $920.8M | $1.03B | $1.24B | $1.22B |
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | $222.8M | $267.5M | -$62.1M | $166.2M | $204.0M | $179.8M |
| Capital expenditures | $92.0M | $68.5M | $90.3M | $83.9M | $79.4M | $88.0M |
| Free cash flow | $130.7M | $199.0M | -$152.4M | $82.3M |
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/ICUI/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/ICUI/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"| $824.8M |
| $822.0M |
| R&D expense | $42.9M | $47.5M | $93.0M | $85.3M | $88.6M | $87.5M |
| SG&A expense | $284.0M | $302.6M | $608.3M | $606.7M | $638.8M | $625.2M |
| Operating income | $98.2M | $123.2M | -$42.9M | $22.8M | $43.0M | $42.8M |
| EBITDA | $183.8M | $212.9M | $192.3M | $251.6M | $262.5M | $243.6M |
| Interest expense | $1.8M | $858K | $75.0M | $133.9M | $133.3M | $104.1M |
| Pretax income | $97.5M | — | — | -$78.3M | -$66.0M | $4.4M |
| Income tax | $10.6M | $20.1M | $40.1M | $48.6M | $51.7M | $2.4M |
| Net income | $86.9M | $103.1M | -$74.3M | -$29.7M | -$117.7M | $732K |
| EPS (diluted) | $4.02 | $4.74 | $-3.11 | $-1.23 | $-4.83 | $0.03 |
Standardized from ICU MEDICAL INC/DE's SEC filings — per-share figures split-adjusted. Full history via the API.
| $1.44B |
| $1.19B |
| Property, plant & equipment | $466.6M | $468.4M | $636.1M | $612.9M | $442.7M | $451.8M |
| Goodwill | $33.0M | $43.4M | $1.45B | $1.47B | $1.43B | $1.50B |
| Total assets | $1.76B | $1.88B | $4.52B | $4.38B | $4.20B | $4.05B |
| Total current liabilities | $195.5M | $200.8M | $494.6M | $481.8M | $556.2M | $498.9M |
| Long-term debt | — | — | $1.62B | $1.58B | $1.53B | $1.27B |
| Total debt | — | $0 | $1.65B | $1.63B | $1.58B | $1.28B |
| Total liabilities | $261.4M | $264.7M | $2.43B | $2.26B | $2.24B | $1.93B |
| Retained earnings | $808.7M | $911.8M | $837.5M | $807.8M | $690.2M | $690.9M |
| Total equity | $1.50B | $1.62B | $2.09B | $2.12B | $1.97B | $2.12B |
| $124.7M |
| $91.8M |
| Investing cash flow | -$98.1M | -$90.7M | -$1.91B | -$87.9M | -$89.0M | $122.2M |
| Financing cash flow | -$40K | -$16.9M | $1.64B | -$36.0M | -$55.8M | -$311.5M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 | $0 |
| Share repurchases | $12.9M | $8.3M | $10.9M | $9.3M | $12.0M | $8.8M |